Upper-gastrointestinal tract involvement showed a numerical trend towards increased response, but not reaching statistical significance as a univariable predictor [OR 3.72; 95% CI 0.89–15.6].
← all excerpts
Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.
1
—
—